Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tolerability and pharmacokinetics of TB-402 in healthy male volunteers.
Verhamme P, Pakola S, Jensen TJ, Berggren K, Sonesson E, Saint-Remy JM, Balchen T, Belmans A, Cahillane G, Stassen JM, Peerlinck K, Glazer S, Jacquemin M. Verhamme P, et al. Among authors: peerlinck k. Clin Ther. 2010 Jun;32(6):1205-20. doi: 10.1016/j.clinthera.2010.06.012. Clin Ther. 2010. PMID: 20637972 Clinical Trial.
Pharmacotherapy with oral Xa inhibitors for venous thromboembolism.
Vanassche T, Vandenbriele C, Peerlinck K, Verhamme P. Vanassche T, et al. Among authors: peerlinck k. Expert Opin Pharmacother. 2015 Apr;16(5):645-58. doi: 10.1517/14656566.2015.999043. Epub 2015 Jan 2. Expert Opin Pharmacother. 2015. PMID: 25554350 Review.
Targeting Coagulase Activity in Staphylococcus aureus Bacteraemia: A Randomized Controlled Single-Centre Trial of Staphylothrombin Inhibition.
Peetermans M, Liesenborghs L, Peerlinck K, Wijngaerden EV, Gheysens O, Goffin KE, Hoylaerts MF, Jacquemin M, Verhaegen J, Peetermans WE, Verhamme P, Vanassche T; Staphylothrombin Investigators. Peetermans M, et al. Among authors: peerlinck k. Thromb Haemost. 2018 May;118(5):818-829. doi: 10.1055/s-0038-1639586. Epub 2018 Apr 3. Thromb Haemost. 2018. PMID: 29614521 Clinical Trial.
Venous Thromboembolism in Patients Discharged after COVID-19 Hospitalization.
Engelen MM, Vandenbriele C, Balthazar T, Claeys E, Gunst J, Guler I, Jacquemin M, Janssens S, Lorent N, Liesenborghs L, Peerlinck K, Pieters G, Rex S, Sinonquel P, Van der Linden L, Van Laer C, Vos R, Wauters J, Wilmer A, Verhamme P, Vanassche T. Engelen MM, et al. Among authors: peerlinck k. Semin Thromb Hemost. 2021 Jun;47(4):362-371. doi: 10.1055/s-0041-1727284. Epub 2021 Apr 23. Semin Thromb Hemost. 2021. PMID: 33893631 Clinical Trial.
Thromboprophylaxis in COVID-19: Weight and severity adjusted intensified dosing.
Engelen MM, Vandenbriele C, Spalart V, Martens CP, Vandenberk B, Sinonquel P, Lorent N, De Munter P, Willems R, Wauters J, Wilmer A, Dauwe D, Gunst J, Guler I, Janssens S, Martinod K, Pieters G, Peerlinck K, Verhamme P, Vanassche T. Engelen MM, et al. Among authors: peerlinck k. Res Pract Thromb Haemost. 2022 Apr 5;6(3):e12683. doi: 10.1002/rth2.12683. eCollection 2022 Mar. Res Pract Thromb Haemost. 2022. PMID: 35415384 Free PMC article.
Clinical application of multigene panel testing for bleeding, thrombotic, and platelet disorders: a 3-year Belgian experience.
Van Laer C, Jacquemin M, Baert S, Labarque V, Thys C, Vanassche T, Van Geet C, Verhamme P, Willekens K, Corveleyn A, Peerlinck K, Freson K. Van Laer C, et al. Among authors: peerlinck k. J Thromb Haemost. 2023 Apr;21(4):887-895. doi: 10.1016/j.jtha.2022.12.007. Epub 2022 Dec 22. J Thromb Haemost. 2023. PMID: 36696193 Free article.
191 results